Shenzhen Chipscreen Biosciences Co (688321) — Capital Reinvestment Ratio
Shenzhen Chipscreen Biosciences Co (688321) has a Capital Reinvestment Ratio of 27.48x as of September 2025, meaning it reinvests 27% of its operating cash flow (CN¥2.25 Million) in capital expenditures (CN¥61.73 Million). See Shenzhen Chipscreen Biosciences Co free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Chipscreen Biosciences Co Capital Reinvestment Ratio (2016–2024)
This chart tracks Shenzhen Chipscreen Biosciences Co's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Shenzhen Chipscreen Biosciences Co (2016–2024)
Year-by-year Capital Reinvestment Ratio for Shenzhen Chipscreen Biosciences Co from 2016 to 2024. For live market cap and broader valuation context, see Shenzhen Chipscreen Biosciences Co (688321) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.53x | CN¥76.13 Million | CN¥268.49 Million | ▼ -61.8% |
| 2022 | 9.24x | CN¥43.30 Million | CN¥400.17 Million | ▲ +299.8% |
| 2021 | 2.31x | CN¥124.78 Million | CN¥288.46 Million | ▼ -35.6% |
| 2020 | 3.59x | CN¥93.62 Million | CN¥336.27 Million | ▼ -41.9% |
| 2018 | 6.18x | CN¥22.78 Million | CN¥140.74 Million | ▼ -87.3% |
| 2017 | 48.65x | CN¥2.73 Million | CN¥132.82 Million | ▲ +4318.2% |
| 2016 | 1.10x | CN¥59.77 Million | CN¥65.81 Million | — |